Exposure to arsenite inhibits protein synthesis and activates multiple stress-signaling pathways. Although arsenite has diverse effects on cell metabolism, we demonstrate phosphorylation of eukaryotic translation initiation factor 2 at Ser 51 on the alpha subunit is necessary to inhibit protein synthesis initiation in arsenite-treated cells and is essential for stress granule formation. Of the four protein kinases known to phosphorylate eIF2 , only the heme-regulated inhibitor kinase (HRI) is required for the translational inhibition in response to arsenite treatment in mouse embryonic fibroblasts. In addition, HRI expression is required for stress granule formation and cellular survival after arsenite treatment. In-vivo studies elucidated a fundamental requirement for HRI in murine survival upon acute arsenite exposure. The results demonstrate an essential role for HRI in mediating arsenite stress-induced phosphorylation of eIF2 , inhibition of protein synthesis, stress granule formation, and survival.
Introduction
The aqueous form of the trivalent arsenical is a potent environmental toxin that significantly contributes to human pathogenesis. Exposure to the arsenite anion (AsO 3 -) results in skin disease, cancer, peripheral neuropathy, and cardiovascular disease [1] . Arsenite exposure is also causative of diabetes [2] . Unfortunately, chronic exposure to arsenite through contaminated water occurs frequently and contributes to carcinogenicity as well as neurological and renal pathology [3] . Based upon incidence, toxicity and potential for human exposure, this toxin is ranked as the number one hazardous substance [4] . Higher doses of arsenite (>5 M) damage different tissues by induction of apoptosis and necrosis. The dose-dependent and tissue-dependent apoptosis induced by arsenite has led to the use of this compound for the treatment of certain types of cancer including acute promyelocytic leukemia and multiple myeloma [5, 6] . As an issue of major public health concern and its potential application to treat cancer, it is essential to obtain an understanding of the mechanisms mediating arsenite toxicity as well as those affording protection against arsenite exposure.
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The physiologically important biological target(s) of arsenite exposure is unknown. Arsenite-induced stress is thought to be the chemical paradigm of heat stress. It is believed that acute arsenite toxicity is due to oxidation of cysteine residues in target proteins that directly alter their conformation and/or activity [7] . Therefore, many cellular responses to arsenite exposure may be a consequence of protein misfolding due to arsenite modification. Compounding the production of unfolded protein, the ubiquitin-proteosome pathway responsible for degrading misfolded and damaged proteins is impaired upon arsenite exposure [8] . Alternatively, arsenite may interact with cysteinerich, redox-sensitive molecules, such as thioredoxin and glutathione, to generate oxidative stress and interfere with specific biological processes.
Exposure to arsenite influences numerous signal transduction pathways that include activation of the stress-activated, mitogen-activated protein (MAP) kinases, extracellular regulated kinase (ERK), c-jun aminoterminal kinase (JNK) and p38 to induce AP-1-dependent transcription [9] [10] [11] .
In addition, arsenite inactivates proinflammatory NF B signaling pathway through inhibition of I B kinase [12] , inhibits of the STAT family of transcription factors [13] , and activates heat shock transcription factor [14] . As a consequence, arsenite suppresses expression of genes encoding anti-apoptotic functions and induces transcription of genes encoding pro-apoptotic functions, cytosolic protein chaperones and other stressresponse genes, such as CHOP/GADD153 and metallothionein [15] [16] [17] [18] . One of the most immediate cellular responses to arsenite exposure is inhibition of protein synthesis that correlates with phosphorylation of the eukaryotic translation initiation factor 2 at Ser51 on the alpha subunit (eIF2 ) [19] [20] [21] . Phosphorylation of eIF2 is a fundamental regulatory mechanism that controls global rates of protein synthesis in all eukaryotic cells [20] . Eukaryotic translation initiation factor 2 is a heteromeric GTP-binding protein that binds initiator tRNA i
Met to form a ternary complex required for 40S ribosomal subunit recognition of the AUG initiation codon within mRNAs. Prior to 60S ribosomal subunit joining, GTP is hydrolyzed to GDP. In order to catalyze another round of initiation, it is necessary to exchange GDP for GTP. As this spontaneous exchange rate is slow, this reaction requires catalysis by the guanine nucleotide exchange factor eIF2B.
Since the cellular amount of eIF2B is limiting over the amount of eIF2 [22] , continued protein translation initiation requires catalytic recycling of eIF2B. The recycling of eIF2B is regulated by phosphorylation of eIF2 at residue Ser51. Phosphorylation at this site increases the affinity of eIF2-GDP for eIF2B by 150-fold [23] . As a consequence, eIF2B is sequestered in a nonproductive complex with eIF2-GDP and prevents further initiation events. Therefore, small increases in the level of phosphorylated eIF2 profoundly inhibit the cellular protein synthetic rate. Such a drastic reduction in the rate of translation upon arsenite exposure may be an adaptive mechanism to conserve cellular energy and resources and to prevent the further accumulation of unfolded protein.
It was previously demonstrated that arsenite treatment induces phosphorylation of eIF2 [21] . There are four protein kinases known to phosphorylate eIF2 at Ser 51 in mammalian cells: the double-stranded RNA activated protein kinase PKR [24] , the mammalian homologue of yeast GCN2 [25] , the endoplasmic reticulum (ER) -localized eIF2 kinase PERK/PEK [26, 27] , and the heme-regulated inhibitor kinase HRI [28] . Although these protein kinases are homologous in their kinase catalytic domains, they each have different regulatory domains that respond to different stress stimuli. PKR gene expression is induced by class 1 interferons and the protein is translated in a latent form that requires activation by binding to highly-structured or double-stranded RNA. GCN2 is activated by amino acid starvation and mediates translational and transcriptional adaptation to amino acid limitation. PERK is activated by the accumulation of unfolded proteins in the ER. HRI is expressed most abundantly in erythroid cells. HRI is the most important eIF2 kinase in erythroid cells where it is activated by deficiency in heme, the prosthetic group of hemoglobin, through two heme-binding domains. In this manner, HRI coordinates globin mRNA translation with available iron [29] . HRI is required to prevent accumulation of misfolded globin chains in the absence of heme. Previous studies demonstrated that arsenite mediates phoshorylation of eIF2 through HRI in erythroid cells [30] . However, it is not known which, if any, of these eIF2 kinases mediates the translational inhibition by arsenite in non-erythroid cells.
Environmental stress initiates the appearance of phase-dense particles termed stress granules (SGs) that were first identified upon heat treatment of tomato cells in culture [31] . SG assembly occurs when translation initiation is aborted. When translation is initiated in the absence of functional eIF2-GTP-tRNA i Met , the 40S ribosome stalls on the mRNA to form a 48S preinitiation complex. These complexes of 40S ribosomes, initiation factors, and their associated mRNA transcripts accumulate to form SGs. SG formation requires TIA-1 (T-cell internal antigen 1) and TIAR (TIA-1-related protein) proteins [32, 33] .
The mRNAs in SGs are in dynamic equilibrium with the polysomes [34] . Stress granule formation in response to ER stress requires the ER stress kinase PERK [35] . Although depletion of the eIF2-GTP-tRNA i Met ternary complex correlates with SG formation, it is not known whether eIF2 inactivation through eIF2 phosphorylation is required for SG formation [36] .
In this study we demonstrate the inhibitory effect of arsenite on protein synthesis is mediated through phosphorylation at Ser51 on eIF2 . Phosphorylation of eIF2 was necessary for arsenite-mediated inhibition of protein synthesis and SG formation. We demonstrate that HRI is expressed and is required for eIF2 phosphorylation to inhibit protein synthesis in response to arsenite-induced stress in murine embryonic fibroblasts (MEFs). The significance of arsenite-induced protein synthesis inhibition was corroborated in vivo as HRI was required for survival when cells or mice were exposed acutely to arsenite.
Experimental Procedures
Generation of kinase-null mice and MEFs. Homozygous HRI -/-mutant mice [37] and mice with the Ser51Ala allele of eIF2 [38] were generated as previously described. PKR -/-mutant mice were kindly provided by Brian Williams [39] .
MEFs were generated using standard isolation procedures [40] . PERK -/-mutant GCN2 ; purified water to a final reaction volume of 20 l. The reaction was heated to 50 C for 1 h, then 75 C for 10 min. The resulting cDNA was purified using a PCR purification column (Qiagen, Valencia, CA) and eluted in 30 L water. cDNA eluate (5 L) or HRI cDNA (5 ng) was used as template for the PCR reaction. The PCR was performed using the Advantage cDNA PCR kit (BD Biosciences Clontech, Palo Alto, CA) per the manufacturer's protocol plus 5% dimethylsulfoxide. The specific primers for HRI were 5'-ATGCTGGGGGGCAGCTCC-'3 and 5'-TCATCTCTTCATCCCTCTG-3. The reaction was cycled at 95 for 1 min, then 50 C for 1 min, then 72 C for 2 min for 32 cycles, followed by a final extension of 72 for 2 min. The expected product size for the HRI +/+ MEFs was 1549 base pairs and for the HRI -/-MEFs was 1145 base pairs. The PCR products were electrophoresed on a 0.9% agarose gel for analysis. For Northern blot analysis, total RNA was extracted using the RNAqueous kit(Ambion). RNA was electrophoresed on a formaldehyde gel and then transferred onto a nylon membrane for hybridization to a digoxygenin-labeled DNA probe specific to HRI. Detection was performed using anti-digoxygenin alkaline phosphatasecomplexed antibody. Protein synthesis analysis. MEF cultures were grown overnight after passage and incubated for 30 min at 37 C in media containing 0-200 M arsenite or 1 M thapsigargin. Cells were rinsed with phosphatebuffered saline (PBS) and then radiolabeled with 200 Ci/ml [ 35 S]-methionine and cysteine (Specific activity = >1000 Ci/mmol; Amersham Corp, Piscataway, NJ) in methionine-and cysteine-free media (Gibco Corp.) for 10 min. After washing with ice-cold PBS, cell extracts were prepared. Radioactivity incorporated was measured by precipitation with 10% trichloroacetic acid and scintillation counting. Some cell extracts were analyzed by SDS-PAGE and prepared for autoradiography using EnHance (NEN Life Science Products, Inc., Boston, MA).
Western blot analysis.
MEFs were cultured and treated as indicated. Cell extracts were prepared with lysis buffer (50 mM Tris pH=7.4, 150 mM NaCl, 10 mMglycerolphosphate, 50 mM NaF, 1 mM orthovanadate, 0.1 mM EDTA, 10% glycerol, 1% Triton X-100 and Boehringer Mannheim Complete mini-protease inhibitors). Proteins were analyzed by SDS-PAGE on reducing gels and the phosphorylated and total forms of eIF2 were detected by Western blot analysis as previously described [41] . Antibody for phosphorylated eIF2 was obtained from Biosource (Camarillo, CA) and mouse monoclonal antibody was used for detection of total eIF2 [41] . Anti-phospho-p38 antibody was obtained from Cell Signaling Technology, Beverly, MA. Densitometry scanning was performed and quantified with Image J software obtained from the NIH website. Polysome profile analysis. Cells in log phase growth were treated with cycloheximide (20 g/mL for 10 min) prior to being scrape-harvested and processed for polysome analysis essentially as described [42] . The fractionated polysomes were eluted using an ISCO fractionator, with continual monitoring at OD 254 . Immunofluorescence of stress granules. Cells were treated with different stress treatments including graded concentrations of sodium arsenite for 45 min, heat shock (44 C for 1 h), puromycin (20 g/mL for 2 h), and glucose starvation. After treatment, the cells were fixed and stained for goat polyclonal antibodies against TIA-1 (T cell intracellular antigen-1) (# sc-1751, Santa Cruz Biotech.), eIF3 (# sc-16378, Santa Cruz Biotech.), and other SG markers as described previously [33] . MEFs were transfected using QIAGEN reagent as previously described [32] . Cell viability assay. MEF cells were cultured in 96 well plates overnight before exposure to media containing sodium arsenite. Cell viability was measured with a ProCheck Cell Viability Assay Kit (Serologicals Corp., Norcross, Ga.). The assay is based on the conversion of an oxidized tetrazole to a reduced form by mitochondria in metabolically active cells. The absorbance at 480 nm is proportional to the number of viable cells. Reticulocyte counts were analyzed by Coulter counting based on size. Liver samples were taken at 4 h after injection and extracts prepared by homogenization in NP-40 lysis buffer (1% NP-40, 50 mM Tris HCl pH 8.0, 150 mM NaCl) containing protease inhibitors (Boehinger Mannheim), NaF (150 mM), orthovanadate (0.5 mM), -glycerophosphate (50 mM), and phenylmethylsulfonyl fluoride (100 g/ml).
Results

Arsenite-mediated inhibition of protein synthesis requires phosphorylation of eIF2 .
To evaluate the role of eIF2 phosphorylation in the cellular stress response to arsenite, we studied MEFs that harbor a Ser51Ala knock-in mutation into the eIF2 gene [38] . Cells were treated with increasing concentrations of sodium arsenite and then pulse-labeled with [ 35 S]-methionine and cysteine to measure the rates of protein synthesis. Where increasing concentrations of sodium arsenite inhibited protein synthesis greater than 90% in wild-type MEFs, the inhibition was significantly less in the homozygous eIF2 A/A mutant MEFs (Fig. 1A,B) . Although the spectrum of abundant polypeptides synthesized was similar under control and arsenite-treatment conditions, the homozygous eIF2 A/A mutant cells were more resistant to the inhibition mediated by arsenite (Fig. 1A) . In three independent experiments, 50 M sodium arsenite reproducibly inhibited protein synthesis in wild-type MEFs with little change in the homozygous eIF2 A/A mutant MEFs (Fig.  1C) . Immunoblot analysis using antibodies that specifically recognize phosphorylated eIF2 and total eIF2 demonstrated a 3-fold increase in eIF2 phosphorylation in wild-type (S/S) MEFs, where phosphorylation was not detected in the homozygous eIF2 A/A mutant MEFs (Fig. 1D) .
Treatment of cells with sodium arsenite activates p38 MAP kinase [7] . To determine whether arsenite actually induces a stress response in the homozygous eIF2 A/A mutant MEFs, we studied the activation of the p38 MAP kinase cascade by Western blot analysis using an antibody that is specific to phosphorylated p38. The results demonstrated that sodium arsenite activated p38 to a similar level in the wild-type (S/S) and homozygous eIF2 mutant cell lines by comparison to the total eIF2 loading control (Fig. 1D) . Therefore, although arsenite induced a stress response, protein synthesis was not inhibited in the eIF2 mutant cells. In addition, p38 activation did not require eIF2 phosphorylation or translational attenuation.
Arsenite-mediated eIF2 phosphorylation and inhibition of protein synthesis requires HRI.
To evaluate the requirement for the four different eIF2 kinases in arsenite-mediated eIF2 phosphorylation and translational inhibition, we studied arsenite responses in MEFs isolated from mice that harbor gene deletions in the different eIF2 kinases. An initial experiment compared eIF2 phosphorylation in wild-type HRI 2B , and data not shown).
We then analyzed MEFs harboring deletions in each of the eIF2 kinases: HRI, PKR, GCN2 and PERK. Homozygous deletion of PKR, GCN2, or PERK had no effect on the arseniteinduced phosphorylation of eIF2 and inhibition of protein synthesis (Fig. 3A,B) . In contrast, deletion of HRI alone prevented both arsenitemediated eIF2 phosphorylation and translational inhibition. Although there was a background level of eIF2 phosphorylation in the HRI -/-mutant MEFs, this phosphorylation was not increased upon sodium arsenite treatment ( Fig. 3A; lanes  7,8) . Treatment of the MEFs with thapsigargin, an agent that induces ER stress, significantly inhibited protein synthesis in all cell lines except the PERK -/-mutant MEFs (Fig. 3B) , consistent with the role of PERK in translational attenuation on ER stress [26, 27] .
Phosphorylation of eIF2 inhibits translation at the level of initiation and causes dissociation of polyribosomes and accumulation of monoribosomes and ribosomal subunits. Therefore, we analyzed polysome profiles for control and arsenite-treated MEFs (Fig. 4) . These results were quantified by measuring the ratio of polysomes/80S species observed for treated cells relative to cells untreated (values presented in Fig.  4) . Comparison of these ratios between wild-type and mutant MEFs shows the area of polysomes/80S upon arsenite treatment was approximately 2-fold greater in the HRI -/-and eIF2 A/A mutant MEFs compared to their wildtype controls. In addition, this ratio between the PKR -/-MEFs and wild-type MEFs did not significantly differ (0.9) (Fig. 4) . Thus, less polysome dissociation occurred upon arsenite treatment of homozygous eIF2 mutant MEFs and HRI -/-mutant MEFs (Fig. 4 ). These differences in polysome profiles are consistent with the effects of arsenite on protein synthesis in these cells.
Our data support the conclusion that HRI is the dedicated eIF2 kinase that mediates translational control in response to sodium arsenite in MEFs. Since previous studies questioned the significance of HRI detected in non-erythroid cells [43, 44] , we characterized HRI expression.
Unfortunately, immunoblot analysis with several anti-HRI antibodies did not detect HRI in extracts of wild-type MEFs. Therefore, we performed RT-PCR as a more sensitive means to detect whether HRI mRNA is expressed in MEFs. This analysis demonstrated the presence of a 1.5 kb product in wild-type MEFs that was absent in the HRI -/-mutant MEFs (Fig. 5A) . HRI -/-mutant MEFs displayed a 1.1 kb product, consistent with deletion of 404 bases in the mRNA from the HRItargeted allele [37] . In addition, Northern blot analysis detected a minor RNA species of the expected molecular sizes in both the wild-type and HRI -/-cells (Fig. 5B) . Therefore, we conclude that HRI is expressed at a low, but physiologically significant level to mediate arsenite-induced translational attenuation in MEFs.
Phosphorylation of eIF2 is necessary for stress granule formation.
The phosphorylation of eIF2 correlates with the assembly of stress granules (SGs) [32] , discrete cytoplasmic foci at which untranslated mRNAs and stalled preinitiation complexes accumulate in cells subjected to environmental stress [33, 35] . In order to form SGs, it is necessary to inhibit protein synthesis by greater than 90% [34] . Transient over-expression of a non-phosphorylatable mutant of eIF2 (S51A) inhibited the assembly of SGs in cells subjected to arsenite-induced oxidative stress [32] , suggesting that phosphorylated eIF2 is required for SG assembly. Consistent with this hypothesis, we found that wild-type S/S MEFs assembled SGs in response to arsenite, whereas homozygous eIF2 mutant A/A MEFs did not (Fig. 6A, C) . Similar results were observed in cells subjected to heat shock or FCCP (carbonyl cyanide ptrifluoromethoxyphenylhydrazone) -induced energy deprivation (data not shown) indicating that phosphorylation of eIF2 is absolutely required for SG assembly. In addition, the HRI -/-mutant MEFs exhibited a severely impaired ability to form SGs in response to sodium arsenite treatment (Fig. 6B, C) , although their ability to form SGs (and to phosphorylate eIF2 ) in response to heat shock was indistinguishable from that of wild-type MEFs (data not shown). We conclude that arsenite treatment activates HRI, which in turn phosphorylates eIF2 and thus drives SG assembly. In contrast, heat shock likely activates other eIF2 kinases in addition to HRI. To further evaluate the requirement for eIF2 phosphorylation to promote stress granule formation in the Ser51Ala eIF2 mutant MEFs, we transfected these MEFs with expression vectors encoding a Ser51Asp mutant eIF2 to mimic a phosphorylated serine that was previously shown to act as a dominant inhibitor of translation [45] .
Cells were co-transfected with agalactosidase expression vector in order to identify the transfected cells. Analysis of either eIF3 or TIA-1 stress granule markers demonstrated that the homozygous A/A mutant MEFs formed stress granules in the presence of the Ser51Asp mutant eIF2 without any exogenous stress (Fig. 6D) . In contrast, transfection with Ser51Ala mutant eIF2 did not induce the formation of stress granules in these cells (data not shown). Therefore, the homozygous A/A mutant MEFs are able to form stress granules in the presence of a phosphomimetic form of eIF2 . We conclude that phosphorylated eIF2 is both necessary and sufficient for stress granule formation.
The HRI response to arsenite promotes cellular and whole animal survival.
To determine whether HRI serves a protective role in response to arsenite, we measured cell survival after sodium arsenite treatment. After 2 h acute exposure to 100 M arsenite, the survival of HRI -/-mutant MEF cells was significantly lower that wild-type or heterozygous HRI +/-mutant MEFs (Fig. 7A) . However, all cell lines were sensitive to arseniteinduced cell death upon longer periods of treatment. Similar analysis of the homozygous eIF2 A/A MEFs did not yield consistent results, possibly due to their slow growth rate and/or the inability to grow at low density (D. Scheuner and R.J. Kaufman, unpublished) which may reflect an increased sensitivity to oxidative stress, as described for PERK -/-MEFs [50] . To further investigate the role of HRI in survival upon arsenite exposure, we evaluated the toxicity of sodium arsenite in vivo in adult wildtype and HRI -/-mutant mice. In vivo, arsenite is toxic to target tissues such as liver, kidney, and red blood cells [46] [47] [48] . Wild-type HRI +/+ mice were injected with a single dose of arsenite at concentrations of 5-20 mg/kg body weight (Fig.  7B) . The 24 h survival was 58% (7/12 mice) after a dosage of 15 mg/kg, consistent with the reported LD 50 for acute arsenite exposure [49] . The sublethal dosage of 15 mg/kg was used for comparison of survival for wild-type and HRI -/-mutant mice derived from littermates (Fig. 7C) . Where greater than 55% of the wild-type mice survived arsenite injection, only 3% of the HRI -/-mutant mice survived (Fig. 7C) . The body mass and arsenite dosages were comparable between both groups of mice. There was no significant difference in survival after arsenite exposure observed between male and female mice (not shown).
Previously, PKR was suggested to be the eIF2 kinase that is activated in response to arsenite treatment [19] . Therefore, to evaluate the relative roles of PKR and HRI in arsenitemediated toxicity, we crossed the PKR-null mice with the HRI-null mice. The HRI -/-PKR -/-double mutant mice displayed no obvious significant phenotype. MEFs prepared from the HRI -/-PKR -/-double knock-out mice were resistant to translational inhibition in response to arsenite, similar to the HRI -/-single knock-out MEFs (data now shown). Upon injection of arsenite, the survival of PKR -/-mice was similar to the wildtype mice, where the survival of HRI -/-PKR -/-double knock-out mice was reduced to a level comparable to the survival of the HRI -/-single knock-out mice (Fig. 7C) . Therefore, we conclude that PKR, in contrast to HRI, does not provide significant protection to arsenite exposure under these conditions in mice.
Analysis of red blood cells from HRI -/-mice indicated they are more sensitive to oxidative stress, such as that induced by the administration of phenylhydrazine [37] . The survival of phenylhydrazine-treated HRI -/-mutant mice was dramatically reduced and this correlated with red blood cell hemolysis. Therefore, we examined whether the reduced survival of HRI -/-mutant mice in response to arsenite treatment correlated with increased red blood cell hemolysis. Whereas phenylhydrazine significantly reduced the number of red blood cells in the wild-type mice, acute arsenite treatment actually slightly increased the red blood cell count in the HRI -/-mice (Fig. 7D) . Therefore, we conclude that arsenite toxicity of the HRI -/-mice is likely due to defects in other organs that require HRI to protect against arsenite toxicity. Analysis of liver samples from arsenitetreated mice demonstrated a significant increase in phosphorylated eIF2 in wild-type mice, where there was a 2-fold lesser increase in HRI -/-mice (Fig. 7E) . Therefore, upon arsenite treatment, HRI contributes significantly to eIF2 phosphorylation in the liver, however, there are additional kinase(s) that also mediate eIF2 phosphorylation under these conditions. It is possible that another eIF2 kinase may be activated indirectly as a consequence of arsenite treatment, e.g. amino acid starvation may activate PERK. Thus, these studies establish that the HRI kinase not only mediates control of translation in response to arsenite stress, but also identify a mechanism necessary for cellular and whole animal survival upon acute arsenite exposure.
Discussion
Treatment of cells with agents that are known to modify protein structure, such as heat shock or sodium arsenite, produce high levels of phosphorylated eIF2
and inhibit protein translation. However, there is no direct data to support that eIF2 phosphorylation is necessary and/or sufficient to inhibit protein synthesis in arsenite-treated cells, nor has the responsible kinase(s) been identified. Recent studies demonstrate PERK can mediate eIF2 phosphorylation in response to oxidative stress [50] , Although arsenite induces formation of reactive oxygen species, it is not known whether arsenite treatment can activate PERK. Previous studies also suggested that PKR is the eIF2 kinase activated by arsenite [19, 20] . However, since these studies were performed by expression of a trans-dominant negative mutant PKR, it is not known whether the dominant-negative acts through inhibiting PKR activity or interfering with some additional regulator of eIF2 phosphorylation. Another study demonstrated that arsenite induces activation of the PKR activator PACT that was suggested to mediate eIF2 phosphorylation [51] . However, the studies that implicate PKR in the arsenite translational response did not evaluate the potential importance of HRI. We have compared the requirement for PERK, GCN2, PKR, and HRI in the arsenite translational response. Our studies support the idea that arsenite treatment activates HRI to phosphorylate eIF2 and that eIF2 phosphorylation is essential to inhibit protein synthesis. In addition, our studies support that PERK, GCN2, and PKR do not significantly mediate phosphorylation of eIF2 in response to arsenite. It was recently established that HRI is activated by arsenite in erythroid cells [30] . However, it was unknown whether eIF2 phosphorylation is required and whether HRI is expressed at physiologically significant levels to mediate eIF2 phosphorylation and inhibition of translation upon arsenite exposure to nonerythroid cells.
Our findings that support that HRI is the kinase that mediates eIF2 phosphorylation upon arsenite treatment include: 1) arsenite treatment did not induce eIF2 phosphorylation or significantly inhibit protein synthesis in HRI -/-MEFs, whereas protein synthesis was inhibited and eIF2 was phosphorylated in wild-type, GCN2 These results also establish an essential requirement for phosphorylation of eIF2 in SG assembly. Homozygous A/A eIF2 mutant MEFs did not assemble SGs in response to arsenite, heat shock or FCCP. In addition, transfection of a Ser51Asp eIF2 mutant, to mimic the phosphoserine, was sufficient to induce SGs in these cells in the absence of exogenous stress.
These findings indicate that phosphorylation of eIF2 is essential and sufficient for SG assembly. Previous studies demonstrated that acute energy starvation mediated by uncoupling oxidative phosphorylation through FCCP treatment induces the assembly of SGs without detectably increasing the phosphorylation of eIF2 [35] . These findings lead to propose that reduced levels of eIF2-GTPtRNA i
Met ternary complex is the key trigger for SG assembly, rather than phosphorylation of eIF2 per se [33, 35] . It is likely that basal levels of constitutively phosphorylated eIF2 are sufficient to induce SGs in wild-type cells treated with FCCP. Regardless, the essential requirement for phosphorylated eIF2 demonstrated in this study requires a reconsideration of current models for SG assembly [36] , that currently predict that SG assembly is a result of ternary complex insufficiency rather than due to eIF2 phosphorylation per se. The data presented here suggest a more direct role for phospho-eIF2 in SG assembly.
Phosphorylation of eIF2 is implicated in both apoptotic and anti-apoptotic responses. It is proposed that eIF2 phosphorylation promotes apoptosis by preventing translation of inhibitors of apoptosis [41, 52] .
Alternatively, eIF2 phosphorylation is implicated in survival by inhibiting translation when protein-folding conditions are suboptimal and by mediating the preferential translation of protective factors, such as the transcription factor ATF4 [27, 38, 53] . Therefore, it is possible that eIF2 phosphorylation may contribute to both survival and death responses upon arsenite exposure. However, our findings in MEFs and in mice support that HRI-mediated phosphorylation of eIF2 is a protective response to arsenite exposure. In contrast, the utility of arsenite as an anti-cancer agent may be attributed to its effects on another signaling pathway, such as activation of JNK or inhibition of NF B activation [5, 6] . Since HRI-mediated phosphorylation of eIF2 protects cells from arsenite exposure, there should be consideration to developing agents to inhibit HRI that may be used in conjunction with arsenite for therapeutic intervention in cancer.
Chronic arsenite exposure is a major public health concern affecting a large percentage of the world population. We have shown that in vivo survival upon acute arsenite exposure requires HRI activity. eIF2 phosphorylation in liver tissue was increased in an HRI-dependent manner, consistent with reports of liver toxicity and arsenite accumulation in the liver [48, 49] . The identification of HRI as a protective factor for arsenite toxicity may also provide an avenue toward rational development of HRI agonists for the treatment and/or prevention of arseniteinduced disease and death. A. SDS-PAGE analysis of metabolically labeled proteins in cell extracts. B. Quantitation of protein synthesis after treatment with sodium arsenite. Analysis was performed in triplicate as described in Experimental Procedures. SEM error bars were small and not apparent on the graph. C. Protein synthesis after sodium arsenite treatment. MEFs were treated with 100 M sodium arsenite for 30 min and then pulse-labeled with [ 35 S]-methionine and cysteine. Cells were harvested and incorporation measured as described in Experimental Procedures. Results are presented as mean ± SEM from three independent experiments. D. Phosphorylation of eIF2 and p38 upon sodium arsenite treatment. Western blot analysis was performed after exposure of MEFs to 100 M arsenite for 30 min. eIF2 and p38 phosphorylation were quantified and normalized to total eIF2 The ratio of the normalized phosphorylation signal of arsenite treated versus untreated is indicated. anti-phospho-p38, and anti-total eIF2 antibody. eIF2 and p38 phosphorylation were quantified and normalized to total eIF2
The ratio of the normalized phosphorylation signal of arsenite treated versus untreated is indicated. B. MEFs were treated with increasing concentrations of arsenite (0, 10, 50, 200 mM) for 30 min, then pulse-labeled with [ 35 S]-methionine and cysteine, and then harvested as described in Experimental Procedures. Equal amounts of protein extract were analyzed by SDS-PAGE and autoradiography. Quantitation of protein synthesis after treatment with sodium arsenite was performed in triplicate as described in Experimental Procedures. Data are mean ± SEM. A. RNA was extracted from wild-type and HRI -/-mutant MEF cultures and RT-PCR was performed. The amplification primers produce a 1549 bp product from the wild-type HRI mRNA, amplifying from bp 311 of the coding sequence to the stop codon of the mRNA. In the mRNA of the HRI -/-MEFs, the primers amplify a truncated 1145 bp product. B. Northern blot analysis was performed as described in Experimental Procedures. , and PKR -/-HRI -/-double-mutant mice. Mice were injected with 15 mg/kg arsenite and survival was determined after 24 h. N = number of mice. D. Red blood cell counts in phenylhydrazine-and arsenite-treated mice. Mice were treated with phenylhydrazine or arsenite (15 mg/kg) and red blood cell counts were determined as described in Experimental Procedures. E. eIF2 phosphorylation in liver extracts. Wild-type and HRI -/-mice (3 each) were treated with sodium arsenite (15 mg/kg) or vehicle and liver extracts were prepared after 4 h for Western blot analysis using antibodies specific to phosphorylated eIF2 as described in Experimental Procedures. Blots were stripped and reprobed with antibodies specific for total eIF2 . Each lane represents a liver extract sample from different mice. The ratio of phosphorylated to total eIF2 was determined by averaging the densities for each set of three individual mice.
